首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

亚太地区药品合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户

市场调查报告书

商品编码

1494469

亚太地区药品合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户

Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 88 Pages | 订单完成后即时交付

价格

简介目录图表

亚太地区药品合约销售组织市场预计将从2022年的17.0748亿美元成长到2030年的36.4688亿美元。

远距医疗和远距详细资讯的使用不断增加推动亚太地区药品合约销售组织市场

远距医疗和远距详细资讯的日益普及为药品合约销售组织 (CSO) 市场带来了新的机会。数位健康科技的变革性影响重新定义了医病互动，并彻底改变了药品销售的动态。远距医疗具有促进虚拟咨询和参与的能力，为公民社会组织的适应和创新创造了肥沃的土壤。远端详细资讯涉及使用数位管道传达产品资讯并吸引医疗保健专业人员，成为公民社会组织扩大影响范围的策略途径。这项策略变化凸显了製药业为应对市场复杂性所采取的积极主动的方法。透过与公民社会组织合作，这些企业可以接触到专业销售人员，利用外部专业知识来提高市场渗透率并提高销售效率。透过这种协作模式，製药公司可以简化其营运并专注于研发等关键能力，同时利用公民社会组织的特定知识来提高其产品的适销性。製药公司和民间社会组织之间不断加强的合作表明了对适应的奉献精神以及对竞争激烈的製药行业发展动态的深刻把握。它也显示了对资源优化的细緻入微的理解。这种互惠互利的合作关係使收入最大化成为可能，并从战略上将製药公司置于适应性和针对性强的市场策略对于长期成功至关重要的市场中。

亚太地区药品合约销售组织市场概况

近年来，由于对具有成本效益的销售和行销解决方案的需求不断增加，亚太地区药品合约销售组织市场经历了显着增长。儘管这些国家对医疗保健产品的需求很大，但製药公司在进入中国、印度和日本等国家的多元化和偏远市场方面面临挑战。透过将销售和行销职能外包给公民社会组织，公司可以从专业团队的专业知识中受益，而无需大量的基础设施和人员投资。此外，亚太地区慢性病的增加和人口老化的加剧也促进了药品合约销售组织市场的扩大。

数位技术的可用性和采用率不断提高，以及对大量资料来源的轻鬆访问，使製药 CSO 能够收集和分析即时资料，从而帮助其客户使用可行的见解。 2023年4月，赛诺菲中国采用了可扩展的商业无所不在的CRM解决方案，该解决方案将适应其不断发展、动态的业务模式，从而加速数位化转型，并使公司能够继续致力于创新。 Omnipresence CRM 使用先进的分析、资料来源和机器学习来产生见解、支援更好的决策，并为商业团队创造新的机会，以提高敏捷性来加速取得成果。

亚太地区药品合约销售组织市场收入及 2030 年预测（百万美元）

亚太地区药品合约销售组织市场区隔

亚太地区药品合约销售组织市场分为服务、模组、治疗领域、最终用户和国家。

根据服务，亚太地区药品合约销售组织市场分为商业服务和非商业服务。 2022年，商业服务领域在亚太药品合约销售组织市场中占据更大份额。

根据模组，亚太地区药品合约销售组织市场分为联合模组和专用模组。 2022 年，联合模组细分市场在亚太地区药品合约销售组织市场中占据更大份额。

根据治疗领域，亚太地区药品合约销售组织市场分为心血管疾病、肿瘤、代谢性疾病、神经病学、骨科疾病、传染病等。 2022 年，肿瘤学领域在亚太药品合约销售组织市场中占据最大份额。

根据最终用户，亚太地区药品合约销售组织市场分为生物製药公司和製药公司。 2022 年，製药公司细分市场在亚太地区药品合约销售组织市场中占有更大份额。

按国家/地区划分，亚太地区药品合约销售组织市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国在亚太药品合约销售组织市场占据主导地位。

Aenova Holding GmbH、CMIC Holdings Co Ltd、EPS Holdings Inc、IQVIA Holdings Inc、Mednext Pharmaceuticals Pvt Ltd、辉瑞 Inc 和 Syneos Health Inc 是亚太地区药品合约销售组织市场上的一些领先公司。

The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry's proactive approach to navigating the market's complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.

Asia Pacific Pharmaceutical Contract Sales Organizations Market Overview

The Asia Pacific pharmaceutical contract sales organization market has experienced significant growth in recent years owing to the elevated demand for cost-effective sales and marketing solutions. Pharmaceutical companies face the challenge of reaching diverse and remote markets in countries such as China, India, and Japan, despite a significant demand for healthcare products in these countries. By outsourcing sales and marketing functions to CSOs, the companies can benefit from the expertise of specialized teams without the need for extensive infrastructure and personnel investments. Furthermore, the rise in chronic diseases and the growing aging population in the Asia Pacific region have also contributed to the expansion of the pharmaceutical contract sales organization market.

The increasing availability and adoption of digital technologies, and easy access to a large number of data sources allow pharmaceutical CSOs to gather and analyze real-time data, thereby assisting their clients with the use of actionable insights. In April 2023, SANOFI China adopted a scalable, commercial omnipresence CRM solution that would adapt to its evolving, dynamic business model, thereby accelerating digital transformation and allowing the company to continue working toward innovation. Omnipresence CRM uses advanced analytics, data sources, and machine learning to generate insights, support better decision-making, and create new opportunities for commercial teams to speed up results with increased agility.

Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation

The Asia Pacific pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on country, the Asia Pacific pharmaceutical contract sales organizations market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Asia Pacific pharmaceutical contract sales organizations market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Integration of Digital Technologies
- 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
- 5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
- 5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
- 5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Asia Pacific Market Analysis

6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
- 7.3.1 Overview
- 7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
- 7.4.1 Overview
- 7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview
8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
- 8.3.1 Overview
- 8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
- 8.4.1 Overview
- 8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview
9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
- 9.3.1 Overview
- 9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
- 9.4.1 Overview
- 9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
- 9.5.1 Overview
- 9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
- 9.6.1 Overview
- 9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
- 9.7.1 Overview
- 9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
- 9.8.1 Overview
- 9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
- 10.3.1 Overview
- 10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Asia Pacific

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview
12.2 Growth Strategies
- 12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 EPS Holdings Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 IQVIA Holdings Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Syneos Health Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mednext Pharmaceuticals Pvt Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Aenova Holding GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
13.7 Pfizer Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market

List Of Figures

Figure 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Asia Pacific - PEST Analysis
Figure 3. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Asia Pacific Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

02-2729-4219

+886-2-2729-4219

License/价格

亚太地区药品合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户

Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：亚太地区药品合约销售组织市场格局

第 5 章：亚太地区药品合约销售组织市场 - 主要产业动态

第 6 章：药品合约销售组织市场 - 亚太地区市场分析

第 7 章：亚太地区药品合约销售组织市场 - 收入和 2030 年预测 - 按服务

第 8 章：亚太地区药品合约销售组织市场 - 收入和 2030 年预测 - 按模组

第 9 章：亚太地区药品合约销售组织市场 - 收入和 2030 年预测 - 按治疗领域

第 10 章：亚太地区药品合约销售组织市场 - 收入和 2030 年预测 - 按最终用户

第 11 章：亚太地区药品合约销售组织市场 - 国家分析

第 12 章：药品合约销售组织市场 - 产业格局

第 13 章：公司简介

第 14 章：附录

Table Of Contents